Omnicell Supports Pharmacy Advancement Through Unrestricted Grant

Company Partners with EAHP to Increase Patient Safety

March 20, 2017

MOUNTAIN VIEW, Calif.

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced it is providing an unrestricted grant to the European Association of Hospital Pharmacists (EAHP) for the purpose of supporting hospital pharmacy advancement. 

A key component of advancing pharmacy is enabling pharmacists to utilize automation to manage inventory, improve security and tracking, and reduce waste, all of which contribute to decreasing medication errors and increasing patient safety.

Patient safety is a key objective of both Omnicell and EAHP. As such, Omnicell will partner with EAHP, via this grant, to support their continuing goal of improving care and outcomes for patients in the hospital setting. EAHP is now working with its member country associations to implement the European Statements of Hospital Pharmacy within their countries. These statements express commonly agreed upon objectives that every European health system should aim for in the delivery of hospital pharmacy services. Omnicell recognizes the importance of these statements and the positive impact they can have on the European health systems.

“EAHP is committed to ensuring that European national health system pharmacies are equipped with the technology they need to reduce medication errors and increase patient safety,” said Jennie De Greef, chief operating officer of EAHP. “We are pleased to have a partner like Omnicell who shares our dedication to this endeavor.” 

“Omnicell strongly believes that safety is paramount for any facility offering care and we are pleased to offer our support as a Corporate Partner to EAHP, whose main focus is patient safety,” said Randall Lipps, chairman, president, CEO and founder of Omnicell. “We look forward to working with them to help achieve their objectives.”